Public procurement notice: Contract Notice
Published: 2018-07-28
Buyer: The Common Services Agency (more commonly known as NHS National Services Scotland) (“NSS")
Country: UK
Contract type: Supplies
Procedure: Open procedure
CPV classification: 33141510 | 33141520 | 33600000: Pharmaceutical products
Estimated value: 8800000 GBP
Submission deadline: 2018-08-29
Award criteria: The most economic tender

Technical requirements: All deliveries under the framework agreement will be to one central location, namely “The Scottish National Blood Transfusion Service” (SNBTS), Edinburgh.
All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.
Supply of Human Albumin Solution (High strength), 15% — 25% in a range of vial sizes. Details of historical usage is included within the ITT.
The Framework Participants will be required to supply the Goods to the Scottish National Blood Transfusion Service (SNBTS), Edinburgh for use by the Participating Authorities.
The Authority is entitled at its sole discretion to extend the twenty-six (26) month duration of the Framework Agreement by up to twenty two (22) months by giving a minimum of three (3) months written notice of such extension.
All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.
Supply of Human Albumin Solution (Low strength), 4,5% — 5% in a range of vial sizes. Details of historical usage is included within the ITT.
The Framework Participants will be required to supply the Goods to the Scottish National Blood Transfusion Service (SNBTS), Edinburgh for use by the Participating Authorities.
The Authority is entitled at its sole discretion to extend the twenty-six (26) month duration of the Framework Agreement by up to twenty two (22) months by giving a minimum of three (3) months written notice of such extension.
Economic operators may be excluded from this competition if they are in breach of any of the situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015.
a) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation or EMA Marketing Authorisation that has been approved by approved by the MHRA for all tendered Medicines at the date of submission of the tender;
b) Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO9001 or equivalent.
a) Confirmation of existence of a valid and current UK Marketing Authorisation or EMA Marketing Authorisation that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender should be included in the Qualification Envelope of the ITT under the Technical and Professional ability: Quality Control;
b) Confirmation of the existence of valid certification of BS EN ISO 9001 or equivalent. Confirmation of such certification should be included in the Qualification Envelope of the ITT under the Quality Assurance Schemes.
The estimated values referred to in this notice cover the initial twenty-six (26) months duration of the Framework Agreement and the full twenty-two (22) months extension options.

Eligibility requirements: Economic operators may be excluded from this competition if they are in breach of any of the situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015.

Award value: 8800000